Patriot Financial Group Insurance Agency LLC grew its holdings in Sanofi (NASDAQ:SNY – Free Report) by 13.6% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 23,882 shares of the company’s stock after purchasing an additional 2,857 shares during the quarter. Patriot Financial Group Insurance Agency LLC’s holdings in Sanofi were worth $1,152,000 at the end of the most recent quarter.
A number of other hedge funds have also modified their holdings of the business. Northwest Investment Counselors LLC acquired a new stake in shares of Sanofi during the 3rd quarter worth about $29,000. Concord Wealth Partners lifted its stake in shares of Sanofi by 157.8% during the third quarter. Concord Wealth Partners now owns 593 shares of the company’s stock valued at $34,000 after buying an additional 363 shares during the period. Sunbelt Securities Inc. lifted its stake in shares of Sanofi by 72.1% during the third quarter. Sunbelt Securities Inc. now owns 747 shares of the company’s stock valued at $43,000 after buying an additional 313 shares during the period. Fortitude Family Office LLC boosted its position in Sanofi by 708.6% during the third quarter. Fortitude Family Office LLC now owns 752 shares of the company’s stock worth $43,000 after acquiring an additional 659 shares during the last quarter. Finally, UMB Bank n.a. grew its stake in Sanofi by 39.2% in the 3rd quarter. UMB Bank n.a. now owns 1,073 shares of the company’s stock worth $62,000 after acquiring an additional 302 shares during the period. 14.04% of the stock is owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
Separately, StockNews.com cut Sanofi from a “buy” rating to a “hold” rating in a report on Thursday, December 12th.
Sanofi Price Performance
Sanofi stock opened at $52.97 on Wednesday. Sanofi has a 1 year low of $45.22 and a 1 year high of $58.97. The company has a debt-to-equity ratio of 0.17, a quick ratio of 0.65 and a current ratio of 1.00. The firm has a 50 day moving average price of $48.90 and a 200 day moving average price of $52.22. The company has a market cap of $134.43 billion, a price-to-earnings ratio of 27.03, a PEG ratio of 1.19 and a beta of 0.57.
About Sanofi
Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.
Recommended Stories
- Five stocks we like better than Sanofi
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- Survey Reveals: Top 150 Best Coffee Shops for Remote Workers and Business Deals [2025]
- 10 Best Airline Stocks to Buy
- What Does the Future Hold for Eli Lilly?
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Oracle Stock Drops Nearly 14% – Is Now the Time to Buy?
Receive News & Ratings for Sanofi Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sanofi and related companies with MarketBeat.com's FREE daily email newsletter.